`

CIRS - Centre for Innovation in Regulatory Science

Public Policy Offices

revenue-icon Revenue
11M - 100M
funding-icon Total Funding
$1.09M
size-icon Size
11 - 50

Frequently Asked Questions About CIRS - Centre for Innovation in Regulatory Science

What does Cirs - centre for innovation in regulatory science do?+

The Centre for Innovation in Regulatory Science (CIRS) is a neutral, independently managed UK-based subsidiary of Clarivate plc. CIRS provides an international forum for industry, regulators, HTA and other healthcare stakeholders to meet, debate and develop regulatory and reimbursement policy through the innovative application of regulatory science and to facilitate access to pharmaceutical products. It is governed and operated by Clarivate for the sole support of its members activities. The organisation has its own dedicated management and advisory boards, and its funding is derived from membership dues, related activities, special projects and grants

What is Cirs - centre for innovation in regulatory science's industry? +

Cirs - centre for innovation in regulatory science operates in the Public policy offices industry.

What is Cirs - centre for innovation in regulatory science's revenue? +

Cirs - centre for innovation in regulatory science's revenue is 11m - 100m

What is Cirs - centre for innovation in regulatory science's company size? +

Cirs - centre for innovation in regulatory science has 11 - 50 employees.

The Go-to Sales Technology According to G2

G2 Badges Map
Get Started With Clodura
Sign Up

Sign Up for Free

Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.

Supercharge Your Prospecting

Supercharge Your Prospecting

Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.

Grow Your Business

Grow Your Business

Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.